Trial Profile
A phase I trial of nelfinavir (Viracept) in adults with solid tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Nelfinavir (Primary) ; Midazolam
- Indications Solid tumours
- Focus Adverse reactions
- 30 May 2012 Additional lead trial investigator (Giaccone G) identified as reported by ClinicalTrials.gov. (NCT01445106)
- 30 May 2012 Additional lead trial investigator (Giaccone G) identified as reported by ClinicalTrials.gov. (NCT01445106)
- 23 Mar 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.